G-Ergometrine 0.2 mg/ml (Injection)

1 ml ampoule: ৳ 7.44 (1 x 5: ৳ 37.22)

Medicine Details

Category Details
Generic Ergometrine maleate
Company Gonoshasthaya pharma ltd
Also available as
G ergometrine 0125 mg tablet

Indications

  • Active management of the third stage of labour
  • Treatment and prophylaxis of postpartum haemorrhage
  • Excessive uterine bleeding
  • Postpartum and post-abortion bleeding

Pharmacology

Ergometrine causes contraction of the uterine muscle. At low doses, there is an increase in frequency and amplitude of contractions while at higher doses, the basal tone of the uterus is increased. Ergometrine also causes vasoconstriction of peripheral and cerebral vessels.

Dosage & Administration

  • Intramuscular (Adult): 0.5 mg given with 5 units of oxytocin after delivery of the anterior shoulder of the infant or immediately after delivery.
  • Intravenous (Adult): 0.2 mg via IV injection over at least 1 minute. May follow with oral doses of 0.2 to 0.4 mg 2-4 times daily until the danger of atony or haemorrhage has passed (usually 48 hr).
  • Oral (Adult): 0.2 to 0.4 mg 2-4 times daily until danger of uterine atony and haemorrhage has passed (usually 48 hr). Max duration: 1 wk postpartum.

Interaction

Halothane causes relaxation of uterine muscle and may interfere with ergometrine action. Enhanced uterotonic effect with prostaglandins and oxytocin. Concurrent administration with CYP3A4 inhibitors may lead to vasospasm, cerebral ischaemia, and/or ischaemia of extremities.

Contraindications

  • Pregnancy
  • 1st and 2nd stage of labour
  • Patients with preeclampsia, eclampsia or threatened spontaneous abortion
  • Porphyria

Side Effects

  • Nausea
  • Vomiting
  • Abdominal pain
  • Diarrhoea
  • Headache
  • Dizziness
  • Tinnitus
  • Chest pain
  • Palpitation
  • Bradycardia
  • Transient hypertension and other cardiac arrhythmias
  • Dyspnoea
  • Sometimes rashes
  • Shock

Pregnancy & Lactation

Pregnancy Category X. The drug is contraindicated in women who are or may become pregnant.

Precautions & Warnings

  • Breech and abnormal foetal presentation
  • Hypertension
  • Chronic anaemia
  • Hepatic, renal, respiratory or cardiac impairment
  • Toxemia
  • Lactation
  • Hypocalcaemia. Monitor BP, pulse, and uterine response.

Overdose Effects

Symptoms include peripheral vasoconstriction, encephalopathy, convulsions, respiratory failure, acute renal failure, and temporary lactose intolerance. Treatment is supportive.

Therapeutic Class

Drugs acting on the Uterus

Storage Conditions

  • Intramuscular: Active management of the third stage of labour: Refrigerate at 2-8°C.
  • Intravenous: Refrigerate at 2-8°C.
  • Oral: Store below 25°C.

Related Brands